Lifemd, Inc. · NASDAQ:LFMD
Lifemd — Conversion Labs — Investor Presentation (May 2019)
19 slides from Lifemd's investor presentation, May 14, 2019
Slide 1: Q2 2019 Overview Presentation
oO O)) CONVERSION 7 LABS ecommerce innovation Q2 2019 Overview Presentation
Slide 2: Safe Harbor
Safe Harbor Statements in this presentation that are not descriptions of historical facts are forwarc-looking statements relating to future events, and as such all forwarc-looking statements are made pursuant to the Securities Litigation Reform Act of 1995. Statements may contain certain forward-loo
Slide 3: Corporate Highlights
Corporate Highlights Conversion Labs is a growing e-commerce company creating and scaling Innovative consumer goods and software. Proprietary Products Products protected by patents, trademarks and know-how Proven Business Model The success of our lead brand demonstrates our ability to grow CONVERSIO
Slide 4: Our Business Model
Our Business Model Create/Acquire Optimize Acquire Maximize Fulfill & Ship Brands Conversion Customers Online Customer Value Products © CONVERSION Q2 2019 Overview Presentation
Slide 5: Vertically Integrated Business Model
©) Vertically Integrated Business Model New Product Development & Acquisition Branding of Products, Websites & Advertisements Product Manufacturing & Supply Chain CONVERSION Marketing Technology Platform Call Center Ops Merchant Processing CRM/Data Mgmt Media Buying Select Advertising Partners Deliv
Slide 6: Highly Favorable Industry Dynamics
Highly Favorable Industry Dynamics E-commerce continues to devastate traditional brick-and-mortar retailers * — Traditiona retail ers are going bankrupt at record-high rates. G n many categories, consumers prefer to shop online vs. in a traditional traditiona . Technology give traditiona © Total Urs
Slide 7: The $5 Trillion Dollar Opportunity
The $5 Trillion Dollar Opportunity Its not if, but rather ‘how much’ market share will e-commerce capture? TECH al CHART OF THE DAY * Online retail still represents only a negligible part of Tharrise Ot'e-commerce ithe US total retail sales both in the U.S. and Worldwide sito alo yn esate aleeees *
Slide 8: Strong Corporate Revenue Growth
Strong Corporate Revenue Growth Numbers in Millions Launch of Shapiro MD $7 Gull S52 $5.0 $8.2 2014 2015 2016 2017 2018 © Hee ea - Q2.2019 Overview Presentation
Slide 9: Proven Scalability of Brands
Proven Scalability of Brands Consumer Products Software $3,000,000.00 $350,000.00 $2,500,000.00 $300,000.00 $2,000,000,00 $250,000.00 $1,500,000.00 $200,000.00 150,000.00 $1,000,000.00 $ $100,000.00 500,000.00 ae | $50,000.00 iF Se =- Hf = ai See SS Se eee % eS a PRARRRRARA x RS es se Ss od a a eee
Slide 10: Our Brands
©) Our Brands o Shapiro MD™ E Patented line of hair products containing 3 naturally occurring z 5 DHT blockers in a proprietary base cS) INR Wellness™ riple action beta glucan product formulated to support the immune system and gut health Scarology™ Doctor formulated 3-step scar healing systern cons
Slide 11: SHAPIRO MD
SHAPIRO MD — HAIR GROWTH EXPERTS SHAMPOO "© Product Highlights Developed by distinguished dermatologists Dr. Steven Shapiro, M.D., and Dr. Michael Borenstein, M.D. PhD U.S. Patents; 15 years of product development and formulation work | SHAPIRO) Market Traction 100,000+ customers to-date 550 million
Slide 12: Product Highlights
Product Highlights . Strong clinical backing with 8500+ clinical studies focused on Beta Glucan’s immune supporting properties . FDA approved health claim for B-glucan soluble fiber from oats for reducing plasma cholesterol levels and risk of heart disease a Only marketed B-glucan product containing
Slide 13: Scarology
scarology” THE ULTIMATE SCAR SYSTEM Product Highlights 2 Only scar healing solution delivered through a simple, three-step day and night routine . Contains a fruit acid exfoliator, a scar cream containing 4 proprietary ingredients and scarology” professional grade FDA-cleared silicon treatment strip
Slide 14: PDFSimpli
PDFSimpli Product Highlights 2 PDF Simpli is a SaaS product that allows users to convert, edit and sign PDF documents . Market opportunity for PDF conversion estimated at $700M per year with more than 65M searches per month © Conversion Labs PR acquired 51% of PDF Simpli through a strategic investme
Slide 15: Growth Areas
Growth Areas We believe the following areas represent exciting growth opportunities for Conversion Labs International Expansion Asia, South America and Europe represent large opportunities for our portfolio brands Telemedicine We intend to become a leader in directly marketing Rx drugs to the online
Slide 16: Executive Team
Executive Team Justin Schreiber President & CEO ¢ Founder of JLS Ventures & Co-founder of Conversion Labs. * Successful track record in small cap venture capital ¢ Largest private investor in CVLB © CONVERSION QO) LABS = Stefan Galluppi CTO & COO ¢ Co-Founder of Conversion Labs ¢ Former founding CTO
Slide 17: Clinical Advisory Board
©) Clinical Advisory Board Joseph V. DiTrolio, MD — Clinical Professor of Surg Medical School Diplomate of The American Board of Urology, AOA urology at New Jersey itor of The Journal of Authored of more than 220 peer reviewed Publications on metagenomics and apy em ecology fthe 50 Most influential
Slide 18: Financials
Financials Conversion Labs is a technology driven online marketing company creating shareholder value through responsible, long-term growth of our core online brands. Upcoming Catalysts . Revenue growth . Licensing deals : Expansion into new verticals ° New product launches 2 Influencer endorsements
Slide 19: Investor Contacts
Zz ©) Investor Contacts Justin Schreiber President & CEO justin@conversionlabs.com Stefan Galluppi CTO & COO Stefan@conversionlabs.com, Juan Pineiro Chief Financial Officer juan@conversionlabs.com